Legend Biotech Corp ADR (NASDAQ: LEGN) established initial surge of 0.68% at $44.32, as the Stock market unbolted on Wednesday, before settling in for the price of $44.02 at the close. Taking a more long-term approach, LEGN posted a 52-week range of $27.34-$60.87.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 0.79%. Meanwhile, its Annual Earning per share during the time was 0.79%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 20.29%. This publicly-traded company’s shares outstanding now amounts to $184.03 million, simultaneously with a float of $181.38 million. The organization now has a market capitalization sitting at $8.16 billion. At the time of writing, stock’s 50-day Moving Average stood at $34.45, while the 200-day Moving Average is $36.74.
Legend Biotech Corp ADR (LEGN) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Legend Biotech Corp ADR industry. Legend Biotech Corp ADR’s current insider ownership accounts for 1.44%, in contrast to 46.25% institutional ownership.
Legend Biotech Corp ADR (LEGN) Earnings and Revenue Records
Legend Biotech Corp ADR’s EPS increase for this current 12-month fiscal period is 20.29% and is forecasted to reach 0.64 in the upcoming year.
Legend Biotech Corp ADR (NASDAQ: LEGN) Trading Performance Indicators
Let’s observe the current performance indicators for Legend Biotech Corp ADR (LEGN). It’s Quick Ratio in the last reported quarter now stands at 5.07. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 11.20.
In the same vein, LEGN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.19, a figure that is expected to reach -0.11 in the next quarter, and analysts are predicting that it will be 0.64 at the market close of one year from today.
Technical Analysis of Legend Biotech Corp ADR (LEGN)
Now, what If we examine the latest scores posted by [Legend Biotech Corp ADR, LEGN]. During the last 5-days, its volume was better the volume of 1.53 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 86.72% While, its Average True Range was 83.34%.
Raw Stochastic average of Legend Biotech Corp ADR (LEGN) in the period of the previous 100 days is set at 94.56%, which indicates a major rise in contrast to 90.83% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.73 that was higher than 1.68 volatility it exhibited in the past 100-days period.
